Translational analysis of esophageal adenocarcinoma (EAC) patients treated with oxaliplatin and capecitabine (Xelox) +/- the dual ErbB inhibitor AZD8931 in the DEBIOC study
Lavery A., Stevenson L., McManus D., Gemma E L., M Walker S., Van Schaeybroeck S., VIRDEE P., ELHUSSEIN L., Turbitt J., Miedzybrodzka Z., Petty R., Harkin PD., Kennedy RD., Eatock MM., MIDDLETON M., Thomas A., Turkington RC.